Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rivian Automotive, Inc. (RIVN) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Rivian Automotive, Inc.Trade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Rivian Automotive, Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? Rivian Automotive, Inc. trades at $12.87 (market cap $19.36B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Rivian Automotive, Inc. is far larger — about 10.8× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Rivian Automotive, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rivian Automotive, Inc. for 61 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

RIVNVIR
Market Cap
$19.36B$1.80B
Volume
16,483,6401,782,836
Sector
Consumer CyclicalHealth
52-Week High
$22.45$11.78
52-Week Low
$12.50$5.12
Typical Hold Time
61 Days0 Days
Enterprise Value
$19.40B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rivian Automotive, Inc.

Rivian Automotive (RIVN) trades at $12.95, down 4.36% amid a bearish technical signal despite beating Q3 2026 delivery estimates with 19,248 vehicles. The company maintains negative profitability with a net income margin of -54.95% but shows improving revenue trends, reaching $5.39 billion in 2025. Cash flow remains negative, though operational losses have narrowed significantly from previous years.

The stock presents a high-risk opportunity with Wall Street consensus leaning bullish (48% buy ratings) and a $16.89 price target, implying potential upside. Key risks include persistent cash burn, intense EV competition, and execution challenges in scaling R2 production and autonomy technology, which are critical for achieving profitability.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RIVN
65% Buy35% Sell
Avg holding period · 61 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Rivian Automotive, Inc.

Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.

Read more on RIVN →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →